Apollo Scuttles $2 Billion Takeover Bid for UK's Bodycote
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Apollo Global Management has terminated its pursuit of a potential $2 billion takeover of UK-listed engineering firm Bodycote Plc, according to a report from Investing.com on June 5, 2026. The New York-based private equity giant had been evaluating an offer for the FTSE 250 company, which specializes in thermal processing and specialist thermal spray services for the aerospace, defense, and automotive sectors. The decision represents a significant retreat from a major industrial acquisition and marks a setback for London's beleaguered stock market, which has seen a steady outflow of companies through take-private deals and relocations.
The collapse of this potential deal occurs against a backdrop of heightened private equity interest in undervalued UK-listed industrial companies. In April 2024, Clayton, Dubilier & Rice successfully took UK aerospace and defense supplier Ultra Electronics private in a $3.8 billion deal. Similarly, the London Stock Exchange has witnessed a steady stream of departures, including the $7.1 billion take-private of veterinary drugmaker Dechra Pharmaceuticals by EQT and the $6.7 billion acquisition of packaging firm DS Smith by International Paper. The macro environment features UK base rates steady at 4.75%, with the FTSE 250 index trading near 19,600, approximately 12% below its 2023 peak. The trigger for the withdrawal appears to be a failure to agree on valuation, with Apollo's due diligence likely highlighting operational risks in Bodycote's key automotive end-market, which faces a cyclical downturn, and insufficient projected returns to justify a premium bid in a higher-for-longer financing environment.
Bodycote's share price closed at 715 pence on June 4, 2026, giving the company a market capitalization of approximately £1.3 billion ($1.66 billion). A successful $2 billion takeover would have implied a premium of roughly 20% to that market value. Over the past 52 weeks, Bodycote shares have traded between 590 pence and 830 pence. The company reported 2025 revenue of £875 million with an operating margin of 16.2%. Its net debt stood at £126 million as of its last report, resulting in a net debt-to-EBITDA ratio of 0.8x. By comparison, the FTSE 250 Industrial Engineering sector trades at an average forward P/E of 13.5x, while the S&P 500 Industrial sector commands a multiple of 19.2x. The valuation gap is stark: Bodycote's forward P/E of 11.2x is a 17% discount to its UK peer group and a 42% discount to its US counterparts.
| Metric | Bodycote | FTSE 250 Industrial Avg. | S&P 500 Industrial Avg. |
|---|---|---|---|
| Forward P/E | 11.2x | 13.5x | 19.2x |
| Dividend Yield | 2.8% | 2.5% | 1.6% |
| Debt/EBITDA | 0.8x | 1.5x | 2.1x |
The failed bid is a near-term negative for Bodycote (BO) shares, which had been buoyed by bid speculation, and could trigger a re-rating downward toward 650-680 pence as merger arbitrage funds exit. The event signals broader caution among financial sponsors regarding highly cyclical industrials, potentially dampening bid premiums for similar UK-listed firms like Renishaw (RSW), IMI (IMI), and Senior (SNR). Conversely, it may provide a modest tailwind for competing engineering service providers like Lisi Group or Parker-Hannifin, which could benefit from reduced competitive pressure in the M&A market for assets. A key counter-argument is that Apollo's retreat may simply reflect firm-specific due diligence findings rather than a sector-wide view, leaving the door open for other bidders or a revised approach should Bodycote's share price weaken further. Flow data indicates short-term sellers targeting BO, while long-only UK equity funds are likely reassessing holdings in mid-cap industrials with exposure to slowing auto and general industrial production.
Immediate focus turns to Bodycote's interim trading update scheduled for late July 2026, which will provide clarity on current trading conditions in its key Aerospace, Defense, and Automotive divisions. The next major catalyst for UK M&A sentiment will be the Bank of England's Monetary Policy Committee decision on June 19, 2026, where any signal of rate cuts could revive financing math for private equity deals. Traders will monitor the 700 pence level for BO as critical technical support; a sustained break below could target the 200-day moving average near 675 pence. Should UK mid-cap valuations compress further, evidenced by the FTSE 250 breaking below 19,000, renewed corporate interest in the sector may emerge by Q4 2026, though likely at lower premium levels than previously seen.
The withdrawal signals that private equity remains highly selective and disciplined on price, despite the perceived discount of UK equities. This could compress takeover premium expectations across the sector, particularly for companies with similar cyclical end-market exposures like Melrose Industries (MRO) or Weir Group (WEIR). The event reinforces that a 'UK discount' alone is insufficient to trigger a deal; sponsors require clear visibility on earnings stability and overlap potential. The focus for investors shifts from M&A speculation back to fundamental operational performance and free cash flow generation.
Apollo has a history of disciplined retreats from contested or expensive auctions. In 2022, it abandoned an $11 billion bid for UK telecoms group TalkTalk. More recently, in late 2025, it withdrew from the auction for chemicals distributor Univar Solutions after due diligence. These precedents underscore the firm's focus on achieving targeted internal rates of return, typically above 20%, and its willingness to walk away when those thresholds appear unattainable, even after significant preliminary work and expense.
Bodycote operates two core divisions: Aerospace, Defence & Energy (44% of revenue) and Automotive & General Industrial (56%). The ADE segment provides high-margin, long-cycle services like heat treatment for jet engine components and is considered the crown jewel. The AGI segment is more cyclical, serving automotive transmission and electric vehicle battery components. A buyer would scrutinize the AGI segment's vulnerability to an auto production slowdown and the capital expenditure required to maintain technology leadership in thermal spray coatings for next-generation aerospace engines.
Apollo's withdrawal underscores that deep UK equity discounts alone cannot guarantee deal completion amid high financing costs and cyclical uncertainty.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.